Publikationen in Zusammenarbeit mit Forschern von Harvard Medical School (3)

2020

  1. Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis

    Breast Cancer Research and Treatment, Vol. 180, Núm. 3, pp. 597-609

2018

  1. Management of unresectable, locally advanced pancreatic adenocarcinoma

    Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 113-118

2011

  1. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

    PLoS Biology, Vol. 9, Núm. 11